Home/ Stocks/ IOBT

IO Biotech, Inc. Common Stock

IOBT XNAS

$0.05 +0.05 (+146.13%) ▲ 15-min delayed

Open

$0.03

High

$0.06

Low

$0.03

Volume

265.42M

Market Cap

$2.32M

About IO Biotech, Inc. Common Stock

IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 78 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q3 2025	$0	$-8,378,000	$-0.13
Q2 2025	$0	$-26,217,000	$-0.40
Q1 2025	$0	$-22,421,000	$-0.34
FY 2024	$0	$-95,491,000	$-1.45

TickerDaily Coverage

Why Is IO Biotech, Inc. Common Stock (IOBT) Stock Up 67.8% Today?

Penny Stocks Marcus Rivera · 3h ago

IO Biotech (IOBT) stock exploded 67.8% on Monday, April 6, 2026, closing at $0.0501 on monster...

View All Coverage →

Get IOBT Alerts

Stay ahead with breaking news, price alerts, and expert analysis on IO Biotech, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.